Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Van Elslande

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Pathogens (Basel, Switzerland)|January 21, 2023
Three Cases of Atypical Pneumonia with <i>Chlamydia psittaci</i>: The Role of Laboratory Vigilance in the Diagnosis of PsittacosisSophie Missault, Anne De Meyst, Jan Van Elslande, et al.
Clinical Chemistry and Laboratory Medicine|September 20, 2024
Colorimetric correcting for sample concentration in stool samplesJoris R Delanghe, Jan Van Elslande, Maaike J Godefroid, et al.
Biochemia Medica|April 30, 2021
Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sampleJan Van Elslande, Samira Hijjit, Katrien De Vusser, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 26, 2021
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infectionJan Van Elslande, Matthijs Oyaert, Scott Ailliet, et al.
The Journal of Applied Laboratory Medicine|August 8, 2024
IFN-α2 Autoantibody Screening and Functional Evaluation in Viral and Bacterial InfectionsMaaike Cockx, Sophie Steels, Birthe Michiels, et al.
Acta Clinica Belgica|October 19, 2020
Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020Frank Buntinx, Peter Claes, Marjo Gulikers, et al.
Clinical Chemistry and Laboratory Medicine|May 22, 2019
The sudden death of the combined first trimester aneuploidy screening, a single centre experience in BelgiumJan Van Elslande, Nathalie Brison, Joris R Vermeesch, et al.
Frontiers in Immunology|December 12, 2022
Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workersBram Decru, Jan Van Elslande, Sophie Steels, et al.
Frontiers in Immunology|July 5, 2022
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare WorkersBram Decru, Jan Van Elslande, Sophie Steels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2020
Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct StrainJan Van Elslande, Pieter Vermeersch, Kris Vandervoort, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Pathogens (Basel, Switzerland)|January 21, 2023
Three Cases of Atypical Pneumonia with <i>Chlamydia psittaci</i>: The Role of Laboratory Vigilance in the Diagnosis of PsittacosisSophie Missault, Anne De Meyst, Jan Van Elslande, et al.
Clinical Chemistry and Laboratory Medicine|September 20, 2024
Colorimetric correcting for sample concentration in stool samplesJoris R Delanghe, Jan Van Elslande, Maaike J Godefroid, et al.
Biochemia Medica|April 30, 2021
Delayed diagnosis and treatment of extreme hypertriglyceridemia due to rejection of a lipemic sampleJan Van Elslande, Samira Hijjit, Katrien De Vusser, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 26, 2021
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infectionJan Van Elslande, Matthijs Oyaert, Scott Ailliet, et al.
The Journal of Applied Laboratory Medicine|August 8, 2024
IFN-α2 Autoantibody Screening and Functional Evaluation in Viral and Bacterial InfectionsMaaike Cockx, Sophie Steels, Birthe Michiels, et al.
Acta Clinica Belgica|October 19, 2020
Added value of anti-SARS-CoV-2 antibody testing in a Flemish nursing home during an acute COVID-19 outbreak in April 2020Frank Buntinx, Peter Claes, Marjo Gulikers, et al.
Clinical Chemistry and Laboratory Medicine|May 22, 2019
The sudden death of the combined first trimester aneuploidy screening, a single centre experience in BelgiumJan Van Elslande, Nathalie Brison, Joris R Vermeesch, et al.
Frontiers in Immunology|December 12, 2022
Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workersBram Decru, Jan Van Elslande, Sophie Steels, et al.
Frontiers in Immunology|July 5, 2022
IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare WorkersBram Decru, Jan Van Elslande, Sophie Steels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2020
Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct StrainJan Van Elslande, Pieter Vermeersch, Kris Vandervoort, et al.
Pageof 3